Molecular Partners Total Assets (Quarterly) Analysis

Molecular Partners AG (MOLN)

6.12 +0.76 (+14.18%) USD | NASDAQ | Nov 01, 16:00

6.15 +0.03 (+0.49%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
June 30, 2024	189.80M
March 31, 2024	205.71M
December 31, 2023	236.15M
September 30, 2023	238.40M
June 30, 2023	256.31M
March 31, 2023	267.69M
December 31, 2022	282.87M
September 30, 2022	288.33M
June 30, 2022	313.61M
March 31, 2022	337.76M
December 31, 2021	188.89M
September 30, 2021	188.74M
June 30, 2021	224.74M
December 31, 2020	214.66M
June 30, 2020	77.10M
December 31, 2019	108.30M

Date	Value
June 30, 2019	138.08M
June 30, 2019	138.08M
December 31, 2018	157.59M
June 30, 2018	127.73M
June 30, 2018	127.73M
December 31, 2017	148.26M
June 30, 2017	168.54M
June 30, 2017	168.54M
December 31, 2016	180.92M
June 30, 2016	204.76M
June 30, 2016	204.76M
December 31, 2015	221.96M
June 30, 2015	208.91M
June 30, 2015	208.91M
December 31, 2014	196.21M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

77.10M

Minimum

Jun 2020

337.76M

Maximum

Mar 2022

226.19M

Average

230.45M

Median

Total Assets (Quarterly) Benchmarks

AC Immune SA	264.24M
CRISPR Therapeutics AG	2.340B
Addex Therapeutics Ltd	15.24M
NLS Pharmaceutics Ltd	1.194M
MoonLake Immunotherapeutics	544.88M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	16.74M
Shareholders Equity (Quarterly)	173.06M
Current Ratio	14.58